Cargando…
RIP3‐mediated necroptosis increases neuropathic pain via microglia activation: necrostatin‐1 has therapeutic potential
Neuropathic pain (NP) is a clinical symptom that accompanies many diseases. We investigated the effect of receptor‐interacting protein kinase 3 (RIP3)‐regulated necroptosis on NP and explored its relationship with microglia, in order to provide a theoretical basis for further research and provide ne...
Autores principales: | Fang, Ping, Sun, Gangqiang, Wang, Jingyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487041/ https://www.ncbi.nlm.nih.gov/pubmed/34320280 http://dx.doi.org/10.1002/2211-5463.13258 |
Ejemplares similares
-
Necrostatin-1 Ameliorates Peripheral Nerve Injury-Induced Neuropathic Pain by Inhibiting the RIP1/RIP3 Pathway
por: Liang, Ying-Xia, et al.
Publicado: (2019) -
Necroptosis, necrostatins and tissue injury
por: Smith, Christopher CT, et al.
Publicado: (2011) -
Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications
por: Cao, Liyuan, et al.
Publicado: (2021) -
The Neuroprotective Effects of Necrostatin-1 on Subarachnoid Hemorrhage in
Rats Are Possibly Mediated by Preventing Blood–Brain Barrier Disruption and RIP3-Mediated
Necroptosis
por: Chen, Jingsen, et al.
Publicado: (2019) -
Macrophage Infiltration Initiates RIP3/MLKL-Dependent Necroptosis in Paclitaxel-Induced Neuropathic Pain
por: Ma, Dongyang, et al.
Publicado: (2022)